Cetera Advisor Networks’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$3.34M Sell
48,309
-2,436
-5% -$154K 0.02% 788
2023
Q4
$3.75M Buy
50,745
+8,795
+21% +$576K 0.02% 701
2023
Q3
$2.86M Buy
41,950
+7,719
+23% +$655K 0.02% 750
2023
Q2
$3.21M Buy
34,231
+1,108
+3% +$86.4K 0.02% 680
2023
Q1
$2.25M Sell
33,123
-999
-3% -$64.2K 0.02% 791
2022
Q4
$1.69M Buy
34,122
+23,194
+212% +$948K 0.01% 880
2022
Q3
$355K Buy
10,928
+291
+3% +$12K ﹤0.01% 1499
2022
Q2
$419K Buy
10,637
+938
+10% +$50.2K 0.01% 1391
2022
Q1
$678K Buy
9,699
+170
+2% +$12.4K 0.01% 1118
2021
Q4
$742K Buy
9,529
+4,023
+73% +$355K 0.01% 1041
2021
Q3
$526K Sell
5,506
-481
-8% -$50.8K 0.01% 1191
2021
Q2
$744K Buy
5,987
+3,343
+126% +$399K 0.01% 961
2021
Q1
$348K Buy
2,644
+46
+2% +$6.3K 0.01% 1058
2020
Q4
$344K Buy
+2,598
New +$314K 0.01% 973
2020
Q3
Sell
-2,341
Closed -$204K 1775
2020
Q2
$204K Buy
+2,341
New +$187K 0.01% 1113

Other funds holding EXAS

Cetera Advisor Networks's EXAS Position: Q1 2024 in Review

Cetera Advisor Networks reduced its Exact Sciences (EXAS) stake by 4.8% in Q1 2024, selling an estimated $154K and leaving 48,309 shares worth $3.34M. The position accounts for 0.02% of the portfolio, ranked #788.

Cetera Advisor Networks first reported a position in EXAS in Q2 2020 and has held it in 15 quarters since. The position peaked at $3.75M in Q4 2023. 627 funds tracked by Wall St. Rank hold EXAS as of Q1 2024.

  • Cetera Advisor Networks held 48,309 shares of Exact Sciences worth $3.34M as of Q1 2024.
  • Cetera Advisor Networks sold 2,436 Exact Sciences shares in Q1 2024, an estimated $154K.
  • Exact Sciences made up 0.02% of Cetera Advisor Networks's portfolio in Q1 2024, its #788 holding.
  • Cetera Advisor Networks first reported a position in Exact Sciences in Q2 2020 and has held it in 15 quarters since.
  • Cetera Advisor Networks's Exact Sciences position peaked at $3.75M in Q4 2023.
  • 627 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.